Member Info for Siddeek

What is the basis of your prediction of 80p when there are more buys than sells almost every day including today at this point of time when I write this post?

So it. Now it might go up above 105P before 4.30 PM in my opinion. It looks like around 93P is the bottom today.

I might even go below 100P since it opened below 100P IMO.

I think it will come down at least 10% to 15%. It moved too soon yesterday, IMO.

Can anyone tell me the last date I can sell my rr. rights?

Debt is a worry for a company which does not have sufficient cash flow. But RDSB has an Interest Cover of more than 22 times with about only 43% debt/equity ratio, with more current assets than borrowing as per the balance sheet of 31st December 2019. IMO, it is a healthy balance sheet. Borrowing is only about 81B but PPE is massively more than 238B!

I cannot understand why this company is trading so low with 8 times of interest cover, continuous profit growth, sales growth, growth in shareholders' fund, growing cash flows from operating activities, with free cash flows, growth in revenue per share, high ROCE, regular dividend, decrease in gearing etc as per some past published accounts. Can someone explain to me the reasons for so low share price?

At this point in time, there are more buys than sales.

On the ex-rights day, 28th Oct, RR shares were traded even at more than 101P. I do not think that the investors who bought at this price bought them without any clues, IMO. They know about the company better than us I believe.

I think JP Morgan analyst's assessment is the theoretical ex-rights price of 80P based on around 230P cum-rights price. Therefore, the current price of RR should hang around 80P very soon IMO. The stock market does not work the way you think IMO.

On what basis you are making this prediction?

On what basis you are making this prediction? The past experience does not strongly support this theory!.

It's not double, but it's about ten times of GSK, I think. Please check.

PE of AZN is ten times more. AZN is heavily overpriced, PE is more than 100, IMO. GSK is a very good fortune deliverer for the dividend income investors, but not for the traders IMO!.

Yes, daily trade is about 0.1% of the total issued shares of GSK. How does it compare with other pharma companies? It is about the same for AZN!

Got it 1379!

Nearly 14 million shares were bought yesterday.

So, the market price might shoot up to two months high today IMO.

What is the chance of this company going bust? I want to invest in the company. But scared.

Then, what is the chance of this company going bust if it is not rescued by this rights issue?